top of page


MedInvest MedTech, AI, and Digital Health Conference
June 10-11, 2026 | New York
Recent Video Content
Recent Articles


GenBio AI: The First Digital Living System
GenBio AI is an AI company headquartered in Silicon Valley with hubs in Paris and the UAE that is developing a new way to understand and program human biology. The company is building AIDO, the AI-Driven Digital Organism, to address a fundamental limitation in traditional biomedical research. Today, most research analyzes DNA, RNA, proteins, cells, and tissues separately. Biology does not function in separate parts. It operates as an interconnected system. GenBio AI aims to d


Conan MedTech: Diagnosing Concussions Immediately
Bayan A. Alturkestani, founder and CEO of Conan MedTech had her “Aha!” moment while working on testing a potential drug for treating mild Traumatic Brain Injury also known as concussion and studying its effect on motor function in 2019: What would be the point, she wondered, in developing drugs to immediately treat concussion victims, if the concussions cannot be immediately diagnosed? Eventually this experience led to her decision to start working on developing a diagnostic


Placing Bone Where More Bone is Needed Most
The story of Lenoss Medical begins with CEO and President, Dom Messerli, a spine industry veteran with 30 years of experience at large medical device corporations, thinking there must be a better way of repairing vertebral compression fractures due to Osteoporosis. Osteoporosis can quietly weaken your bones over time-especially the ones in your spine called vertebrae. When these bones become too fragile, they can collapse resulting in a vertebral compression fracture, or VCF


Azalea Vision – The First Smart Lens That Turns Tears into Real-Time Health Data
Azalea Vision is redefining how to correct, manage, and interact with health and vision. Born as a spin-off from imec and Ghent University, Azalea Vision is developing the first medical-grade smart lens platform that adapts, connects, and responds in real time—bringing a new level of intelligence to ophthalmic care. Azalea’s lens-embedded system combines adaptive optics, embedded microelectronics, and NFC connectivity to deliver both therapeutic and diagnostic functions wit


TaiMed Biologics: Advancing Next-Generation HIV Therapies
TaiMed Biologics is a clinical-stage biopharmaceutical company specializing in the development and manufacturing of innovative biologics,...


Bench side-to-patient side products and services on a single scalable foundational platform
As the functional units, the most clinically important molecules in our bodies are proteins and proteoforms. Variations in the...


DIMERx advancing DMX-101 as first-in-class, non-addictive oral therapeutic for pain
DIMERx is an NIH-funded, clinical-stage U.S. biopharmaceutical company pioneering a new class of dimer therapeutics to address two urgent...


Avanti Biosciences: From Neurodegeneration to a Breakthrough in Fibrosis
Avanti Biosciences, founded in 2009 in New York by Dr. Gian Luca Araldi, began its journey in the world of biotechnology as a nimble...


BioT: Redefining Care with the Right Infrastructure for Medical Device Clouds
In a world where healthcare innovation is paramount, BioT emerged with a vision: to create an infrastructure that enables medical device...


MedInvest Semiannual MedTech, AI, and Digital Health Conference Scheduled For December 10-11, 2025 in NYC
MedInvest, a leading healthcare, biotech, and medtech media and conference company, scheduled its semiannual MedTech, AI, and Digital Health Conference for December 10-11, 2024 in New York City. Goodwin Law Firm and the National Institutes of Health will be presenting partners of the event. The conference is expected to attract 100+ investors spanning venture and public funds, family offices, strategics, and government and non-profit grant making entities and over 50 presen


DrNose Diagnoses Cancers by Smelling your Breath
A mother had lung cancer and was cured. Unfortunately, by the time she went for her regular check-up, they found she had relapsed and was...


AcuamarkDx: Pioneering a Transformative Approach to Early Cancer Diagnostics
AcuamarkDx is pioneering a transformative approach to early cancer diagnostics with its proprietary qPCR and methylation-based...


Breast Cancer Lumpectomy Guidance System Delivers Dramatic Clinical and Cost Improvements
Imagine having been told you have breast cancer, and all the worry that comes with it. Then imagine that, after lumpectomy surgery and a...


Minerva Biotechnologies - Developing Cancer Immunotherapies Targeting 80% of Solid Tumors and to Prevent Cancer Metastasis
“The power which resides in him is new in nature, and none but he knows what that is which he can do, nor does he know until he has...


Cytogel - Developing Safe and Effective Drugs for the Treatment of Pain
Cytogel is a clinical stage bio-pharmaceutical development company focused on the discovery and development of novel analgesics for the...


Monitored Therapeutics: Revolutionizing Respiratory Care
Monitored Therapeutics Inc. (MTI) is revolutionizing respiratory care by addressing the critical issues faced by millions of patients...


Collective Minds: Transforming Healthcare Collaboration
Since its inception in 2017, Collective Minds has been at the forefront of revolutionizing the healthtech industry. The company’s...


MedInvest Semi-Annual MedTech, AI, and Digital Health Conference Announced For June 11-12, 2024
MedInvest, a leading healthcare, biotech, and medtech media and conference company, announced that it will host its semi-annual Medical...


Creating a World Where Cancer Can’t Hide - iCAD’s AI-Powered Mammography Solutions are Revolutionizing Breast Health
When it comes to cancer, hide and seek is no game. Remaining hidden, cancer poses one of the greatest threats to life. But what if...


Unlocking Precision Medicine For Inflammation, The Silent Killer Destroying Our Health
For decades, the pharmaceutical industry has sought to develop targeted, personalized treatments to better serve individual patients....
![]() | ![]() | ![]() |
|---|
© 2020 MedInvest Investor Conference Series
bottom of page






















